aureus abundance and address atopic dermatitis. Sites for the Phase 1 clinical trial of ENS-002, Topical ENS-002 for Atopic Dermatitis in Adults (EnSync), are now open for enrollment. For more ...
The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered ...
Don't Miss our Black Friday Offers: Michael Ulz has given his Hold rating due to a combination of factors including the promising yet preliminary data from Alnylam’s Phase 1 study ... Sharp on June 14 ...
Ipsen to present new data on elafibranor at The Liver Meeting® 2024Launch of Iqirvo® (elafibranor)1 on track with expectations; encouraging feedback from healthcare providers ...